On teste

téphane Bancel predicts there will be a “material drop” in the effectiveness of the current COVID-19 vaccines against the Omicron variant — and said it will take drugmakers months to produce enough targeted jabs for the emerging strain.

Moderna CEO Stéphane Bancel predicts there will be a “material drop” in the effectiveness of the current COVID-19 vaccines against the Omicron variant — and said it will take drugmakers months to produce enough targeted jabs for the emerging strain.

“There is no world, I think, where (the effectiveness) is the same level … we had with Delta,” Bancel told the Financial Times on Monday.

“I think it’s going to be a material drop. I just don’t know how much because we need to wait for the data. But all the scientists I’ve talked to … are like, ‘This is not going to be good,’” he added at the company’s headquarters in Cambridge, Massachusetts.

Moderna CEO Stéphane Bancel predicts there will be a “material drop” in the effectiveness of the current COVID-19 vaccines against the Omicron variant — and said it will take drugmakers months to produce enough targeted jabs for the emerging strain.

“There is no world, I think, where (the effectiveness) is the same level … we had with Delta,” Bancel told the Financial Times on Monday.

“I think it’s going to be a material drop. I just don’t know how much because we need to wait for the data. But all the scientists I’ve talked to … are like, ‘This is not going to be good,’” he added at the company’s headquarters in Cambridge, Massachusetts.

Moderna CEO Stéphane Bancel predicts there will be a “material drop” in the effectiveness of the current COVID-19 vaccines against the Omicron variant — and said it will take drugmakers months to produce enough targeted jabs for the emerging strain.

“There is no world, I think, where (the effectiveness) is the same level … we had with Delta,” Bancel told the Financial Times on Monday.

“I think it’s going to be a material drop. I just don’t know how much because we need to wait for the data. But all the scientists I’ve talked to … are like, ‘This is not going to be good,’” he added at the company’s headquarters in Cambridge, Massachusetts.

Moderna CEO Stéphane Bancel predicts there will be a “material drop” in the effectiveness of the current COVID-19 vaccines against the Omicron variant — and said it will take drugmakers months to produce enough targeted jabs for the emerging strain.

“There is no world, I think, where (the effectiveness) is the same level … we had with Delta,” Bancel told the Financial Times on Monday.

“I think it’s going to be a material drop. I just don’t know how much because we need to wait for the data. But all the scientists I’ve talked to … are like, ‘This is not going to be good,’” he added at the company’s headquarters in Cambridge, Massachusetts.

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée.